Apol1 Mediated Proteinuric Kidney Disease Amkd clinical trials

Explore recruiting apol1 mediated proteinuric kidney disease amkd clinical trials.

Recruiting apol1 mediated proteinuric kidney disease amkd studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Apol1 Mediated Proteinuric Kidney Disease Amkd trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2/3 Adaptive, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VX-147 in Adult and Pediatric Subjects With APOL1-mediated Proteinuric Kidney Disease

Belgium, France

Phase II and Phase III (Integrated) EU CTIS Study details

Apol1 Mediated Proteinuric Kidney Disease Amkd trials by city

Apol1 Mediated Proteinuric Kidney Disease Amkd in Toronto Apol1 Mediated Proteinuric Kidney Disease Amkd in Vancouver Apol1 Mediated Proteinuric Kidney Disease Amkd in Montreal Apol1 Mediated Proteinuric Kidney Disease Amkd in Calgary Apol1 Mediated Proteinuric Kidney Disease Amkd in Edmonton Apol1 Mediated Proteinuric Kidney Disease Amkd in Ottawa Apol1 Mediated Proteinuric Kidney Disease Amkd in Winnipeg Apol1 Mediated Proteinuric Kidney Disease Amkd in Quebec City Apol1 Mediated Proteinuric Kidney Disease Amkd in Hamilton Apol1 Mediated Proteinuric Kidney Disease Amkd in Kitchener Apol1 Mediated Proteinuric Kidney Disease Amkd in London Apol1 Mediated Proteinuric Kidney Disease Amkd in Halifax Apol1 Mediated Proteinuric Kidney Disease Amkd in New York Apol1 Mediated Proteinuric Kidney Disease Amkd in Los Angeles Apol1 Mediated Proteinuric Kidney Disease Amkd in Chicago Apol1 Mediated Proteinuric Kidney Disease Amkd in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease